Photo from wikipedia
DWP16001 is a novel sodium–glucose cotransporter‐2 inhibitor under development for the treatment of type 2 diabetes mellitus. This study was conducted to evaluate the pharmacokinetics, pharmacodynamics and safety of DWP16001… Click to show full abstract
DWP16001 is a novel sodium–glucose cotransporter‐2 inhibitor under development for the treatment of type 2 diabetes mellitus. This study was conducted to evaluate the pharmacokinetics, pharmacodynamics and safety of DWP16001 after single and multiple doses in healthy subjects.
Keywords:
cotransporter inhibitor;
glucose cotransporter;
dwp16001;
dwp16001 novel;
sodium glucose;
healthy subjects
Journal Title: British Journal of Clinical Pharmacology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Clinical Pharmacology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!